These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35243042)

  • 1. Neurocognitive functioning following lung cancer treatment: The PRO-Long Study.
    van der Weijst L; Lievens Y; Surmont V; Schrauwen W
    Tech Innov Patient Support Radiat Oncol; 2022 Mar; 21():36-40. PubMed ID: 35243042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study.
    Van Der Weijst L; Surmont V; Schrauwen W; Lievens Y
    Front Oncol; 2021; 11():685605. PubMed ID: 34222010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
    Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
    Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
    Caramanna I; Reijneveld JC; van de Ven PM; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Klein M;
    Eur J Cancer; 2023 Jun; 186():38-51. PubMed ID: 37028200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
    Li J; Bentzen SM; Li J; Renschler M; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).
    Wefel JS; Armstrong TS; Pugh SL; Gilbert MR; Wendland MM; Brachman DG; Roof KS; Brown PD; Crocker IR; Robins HI; Hunter G; Won M; Mehta MP
    Neuro Oncol; 2021 Jul; 23(7):1125-1138. PubMed ID: 33515019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes.
    Hall WA; Pugh SL; Wefel JS; Armstrong TS; Gilbert MR; Brachman DG; Werner-Wasik M; Wendland MM; Brown PD; Chao ST; Roof KS; Robins HI; Mehta MP; Curran WJ; Movsas B
    Neurosurgery; 2019 Jan; 84(1):66-76. PubMed ID: 29618054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
    Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
    van Kessel E; Baumfalk AE; van Zandvoort MJE; Robe PA; Snijders TJ
    J Neurooncol; 2017 Aug; 134(1):9-18. PubMed ID: 28567586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
    Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
    J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.
    Rogiers A; Leys C; Lauwyck J; Schembri A; Awada G; Schwarze JK; De Cremer J; Theuns P; Maruff P; De Ridder M; Bernheim JL; Neyns B
    J Immunol Res; 2020; 2020():2192480. PubMed ID: 32775464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.
    Armstrong TS; Wefel JS; Wang M; Gilbert MR; Won M; Bottomley A; Mendoza TR; Coens C; Werner-Wasik M; Brachman DG; Choucair AK; Mehta M
    J Clin Oncol; 2013 Nov; 31(32):4076-84. PubMed ID: 24101048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment.
    van Kessel E; Emons MAC; Wajer IH; van Baarsen KM; Broekman ML; Robe PA; Snijders TJ; Van Zandvoort MJE
    Neurooncol Pract; 2019 Dec; 6(6):463-472. PubMed ID: 31832216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study.
    van Kessel E; Snijders TJ; Baumfalk AE; Ruis C; van Baarsen KM; Broekman ML; van Zandvoort MJE; Robe PA
    J Neurooncol; 2020 Jan; 146(1):97-109. PubMed ID: 31802314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
    Li J; Bentzen SM; Renschler M; Mehta MP
    J Clin Oncol; 2007 Apr; 25(10):1260-6. PubMed ID: 17401015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
    Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
    J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy.
    van der Meer PB; Habets EJJ; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Dirven L; Taphoorn MJB
    J Neurooncol; 2018 Sep; 139(2):359-368. PubMed ID: 29663172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired neurocognitive function in glioma patients: from pathophysiology to novel intervention strategies.
    Noll KR; Walbert T; Wefel JS
    Curr Opin Neurol; 2020 Dec; 33(6):716-722. PubMed ID: 33009006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.